RNA binding protein tristetraprolin inhibits proliferation of lung adenocarcinoma cells <italic style="font-style: italic">in vitro</italic>

Qinli LUO; Xiaoya DENG; Fei DONG; Li XU; Tao JIANG

doi:10.16016/j.1000-5404.201811085

您当前的位置：

首页 >

文章列表页 >

RNA binding protein tristetraprolin inhibits proliferation of lung adenocarcinoma cells in vitro

Basic Medicine | 更新时间：2026-01-09

- RNA binding protein tristetraprolin inhibits proliferation of lung adenocarcinoma cells in vitro
- Journal of Third Military Medical University Vol. 41, Issue 9, Pages: 851-858(2019)
- 作者机构：
  
  400016 重庆，重庆医科大学附属第一医院呼吸与危重症医学科
- 作者简介：
- 基金信息：
  
  the General Program of National Natural Science Foundation of China(81602430);the Project of Basic and Frontier Research of Chongqing Science and Technology Commisson(CSTC2016jcyjA0329)
- DOI：10.16016/j.1000-5404.201811085
  CLC： R341;R730.23;R734.2
- Received：12 November 2018，
  
  Revised：2018-12-19，
  
  Published：15 May 2019
- 稿件说明：
移动端阅览
Qinli LUO, Xiaoya DENG, Fei DONG, et al. RNA binding protein tristetraprolin inhibits proliferation of lung adenocarcinoma cells in vitro[J]. Journal of Third Military Medical University, 2019, 41(9): 851-858.
DOI：

Qinli LUO, Xiaoya DENG, Fei DONG, et al. RNA binding protein tristetraprolin inhibits proliferation of lung adenocarcinoma cells in vitro[J]. Journal of Third Military Medical University, 2019, 41(9): 851-858. DOI： 10.16016/j.1000-5404.201811085.

摘要

目的

探讨TTP(tritetraprolin)过表达对肺腺癌细胞增殖影响及其可能的作用机制。

方法

构建带有四环素可调控(tetracycline-on，Tet-on)的TTP基因表达系统，利用慢病毒感染的方法转染肺腺癌H1975及1299细胞，并在强力霉素(doxycycline，Dox)的诱导下稳定表达TTP。用实时荧光定量PCR和Western blot鉴定TTP受Dox调控表达的效果。分别采用CCK-8法、Transwell、平板克隆形成实验、流式细胞术检测TTP过表达后对细胞增殖、迁移、集落形成能力、凋亡和细胞周期的影响。Western blot法检测TTP过表达对凋亡基因在蛋白水平表达的影响。

结果

成功构建受Dox诱导调控的TTP过表达肺腺癌细胞模型。与TTP低表达组比较，Dox诱导TTP过表达组明显抑制H1975、H1299细胞增殖、迁移能力(H1975 :

0.01

H1299:

0.001)及集落形成能力(

值均

0.0001)，且使H1975细胞周期被阻滞在S期(

0.01)，但TTP过表达不影响肺腺癌细胞凋亡。

结论

TTP过表达显著抑制肺腺癌细胞增殖、迁移、集落形成能力，使细胞周期被阻滞在S期，但TTP过表达不通过细胞凋亡途径影响肺腺癌细胞增殖和生长。

Abstract

Objective

To investigate the effect of tristetraprolin (TTP) on the proliferation of lung cancer cells and to explore the possible mechanism.

Methods

The human lung adenocarcinoma cells with tetracycline-inducible (Tet-on) expression regulatory system were established in H1975 and 1299 cells with the aid of lentivirus infection. Western blotting and q-PCR were used to confirm the overexpression of TTP in the cells after the doxycycline (Dox) treatment. Effect of TTP on the proliferation

migration and colony-forming capacity were detected by CCK-8 assay

Transwell test and colony forming unit test respectively. The cell apoptosis and cell cycle were measured by flow cytometry. The expression of cellular apoptosis-related proteins were determined by Western blotting.

Results

Lung adenocarcinoma cells with Dox-induced TTP overexpression were successfully established. Compared with the cells with low TTP expression

those with Dox-induced TTP overexpression siginicantly inhibited proliferation

migration(H1975:

0.01

H1299:

0.001)and colony-formation (all

0.0001) in lung adenocarcinoma cells H1975 and H1299. What's more

H1975 cells were arrested at S stage (

0.01). However

TTP overexpression exerted no effect on cell apoptosis.

Conclusion

TTP overexpression obviously inhibits proliferation

migration and colony-forming capacity

and arrests cell cycle at S stage in lung adenocarcinoma cells. But the mechanism is not due to the regulation of cell apoptosis.

关键词

Keywords

references

OGILVIE R L, ABELSON M, HAU H H, et al . Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay[J ] . J Immunol, 2005, 174(2): 953-961. DOI:10.4049/jimmunol.174.2.953.

WEI Z R, LIANG C, FENG D, et al . Low tristetraprolin expression promotes cell proliferation and predicts poor patients outcome in pancreatic cancer[J ] . Oncotarget, 2016, 7(14): 17737-17750. DOI:10.18632/oncotarget.7397.

GODDIO M V, GATTELLI A, SLOMIANSKY V, et al . Mammary differentiation induces expression of tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein[J ] . Breast Cancer Res Treat, 2012, 135(3): 749-758. DOI:10.1007/s10549-012-2216-0.

HALEES A S, EL-BADRAWI R, KHABAR K S. ARED Organism: expansion of ARED reveals AU-rich element cluster variations between human and mouse[J]. Nucleic Acids Res, 2008, 36(Database issue): D137-D140. DOI:10.1093/nar/gkm959.

BLACKSHEAR P J. Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover[J]. Biochem Soc Trans, 2002, 30(Pt 6): 945-952. DOI:10.1042/.

BAOU M, JEWELL A, MUTHURANIA A, et al . Involvement of Tis11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells[J ] . Leukemia, 2009, 23(5): 986-989. DOI:10.1038/leu.2008.340.

GUO J, QU H, CHEN Y, et al . The role of RNA-binding protein tristetraprolin in cancer and immunity[J ] . Med Oncol, 2017, 34(12): 196. DOI:10.1007/s12032-017-1055-6.

JELTSCH K M, HEISSMEYER V. Regulation of T cell signaling and autoimmunity by RNA-binding proteins[J]. Curr Opin Immunol, 2016, 39: 127-135. DOI:10.1016/j.coi.2016.01.011.

FALLAHI M, AMELIO A L, CLEVELAND J L, et al . CREB targets define the gene expressio n signature of malignancies having reduced levels of the tumor suppressor tristetraprolin[J ] . PLoS ONE, 2014, 9(12): e115517. DOI:10.1371/journal.pone.0115517.

FU M, BLACKSHEAR P J. RNA-binding proteins in immune regulation: a focus on CCCH zinc finger proteins[J]. Nat Rev Immunol, 2017, 17(2): 130-143. DOI:10.1038/nri.2016.129.

BROOKS S A, BLACKSHEAR P J. Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action[J]. Biochim Biophys Acta, 2013, 1829(6/7): 666-679. DOI:10.1016/j.bbagrm.2013.02.003.

GRUBER A R, FALLMANN J, KRATOCHVILL F, et al . AREsite: a database for the comprehensive investigation of AU-rich elements[J ] . Nucleic Acids Res, 2011, 39(Database issue): D66-D69. DOI:10.1093/nar/gkq990.

KHABAR K S A. Hallmarks of cancer and AU-rich elements[J]. Wiley Interdiscip Rev: RNA, 2016, 8(1): e1368. DOI:10.1002/wrna.1368.

BISOGNO L S, KEENE J D. RNA regulons in cancer and inflammation[J]. Curr Opin Genet Dev, 2018, 48: 97-103. DOI:10.1016/j.gde.2017.11.004.

MUKHERJEE N, JACOBS N C, HAFNER M, et al . Global target mRNA specification and regulation by the RNA-binding protein ZFP36[J ] . Genome Biol, 2014, 15(1): R12. DOI:10.1186/gb-2014-15-1-r12.

MUSGROVE E A, CALDON C E, BARRACLOUGH J, et al . Cyclin D as a therapeutic target in cancer[J ] . Nat Rev Cancer, 2011, 11(8): 558-572. DOI:10.1038/nrc3090.

LEE H H, LEE S R, LEEM S H. Tristetraprolin regulates prostate cancer cell growth through suppression of E2F1[J]. J Microbiol Biotechnol, 2014, 24(2): 287-294. DOI:10.4014/jmb.1309.09070.

LEE S R, ROH Y G, KIM S K, et al . Activation of EZH2 and SUZ12 regulated by E2F1 predicts the disease progression and aggressive characteristics of bladder cancer[J ] . Clin Cancer Res, 2015, 21(23): 5391-5403. DOI:10.1158/1078-0432.CCR-14-2680.

ZHANG Y, WANG Z, MAGNUSON N S. Pim-1 kinase-dependent phosphorylation of p21Cip1/WAF1 regulates its stability and cellular localization in H1299cells[J]. Mol Cancer Res, 2007, 5(9): 909-922. DOI:10.1158/1541-7786.MCR-06-0388.

ROUNBEHLER R J, FALLAHI M, YANG C, et al . Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state[J ] . Cell, 2012, 150(3): 563-574. DOI:10.1016/j.cell.2012.06.033.

SANDUJA S, KAZA V, DIXON D A. The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase[J]. Aging (Albany NY), 2009, 1(9): 803-817. DOI:10.18632/aging.100086.

GUO J, QU H, SHAN T, et al . Tristetraprolin overexpression in gastric cancer cells suppresses PD-L1 expression and inhibits tumor progression by enhancing antitumor immunity[J ] . Mol Cells, 2018, 41(7): 653-664. DOI:10.14348/molcells.2018.0040.

TRAN D D H, KOCH A, ALLISTER A, et al . Treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP)[J ] . Cell Signall, 2016, 28(12): 1872-1880. DOI:10.1016/j.cellsig.2016.09.002..

DONG F, LI C, WANG P, et al . The RNA binding protein tristetraprolin down-regulates autophagy in lung adenocarcinoma cells[J ] . Exp Cell Res, 2018, 367(1): 89-96. DOI:10.1016/j.yexcr.2018.03.028.

COELHO M A, DE CARNÉ TRÉCESSON S, RANA S, et al . Oncogenic RAS signaling promotes tumor immunoresistance by stabilizing PD-L1 mRNA[J ] . Immunity, 2017, 47(6): 1083-1099.e6. DOI:10.1016/j.immuni.2017.11.016.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Functional study of LncRNA MUC5B-AS1 in lung adenocarcinoma cell lines

Effect of diosmetin on proliferation, apoptosis and migration of colorectal cancer cells by regulating STX17-AS1/miR-383-5p axis

Expression of LETM1 in hepatocellular carcinoma and its effect on proliferation and apoptosis in hepatocellular carcinoma cell line SMMC-7721

Functions of glypican-5 gene in lung adenocarcinoma cell lines

Expression of miR-616 in osteosarcoma and its role in proliferation, apoptosis, migration and invasion of tumor cells

Related Author

Guilu WANG

Shuai YUAN

Zeyao HU

Qingyun LIU

Ying XIANG

Long WU

Na WU

Chengying LI

Related Institution

Department of Epidemiology, School of Public Health, Guizhou Medical University

Department of Epidemiology, College of Military Preventive Medicine, Third Military Medical University

Department of Thoracic Surgery, Xinqiao Hospital, Third Military Medical University

Institute of Respiratory Diseases, Key Laboratory of Respiratory Diseases, Xinqiao Hospital, Third Military Medical University

Department of Pathology， Second Affiliated Hospital， Army Medical University （Third Military Medical University）

⁰

RNA binding protein tristetraprolin inhibits proliferation of lung adenocarcinoma cells in vitro

DOI：10.16016/j.1000-5404.201811085

摘要

Abstract

关键词

Keywords

references